Current Cancer Drug Targets
Title:Acknowledgements to Reviewers:
Volume: 14 Issue: 9
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers:, Current Cancer Drug Targets 2014; 14 (9) . https://dx.doi.org/10.2174/156800961409150111211723
DOI https://dx.doi.org/10.2174/156800961409150111211723 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radionuclide Based Imaging of Prostate Cancer
Current Topics in Medicinal Chemistry RNAi in Clinical Studies
Current Medicinal Chemistry Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Current Bioactive Compounds Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4
Current Pharmacogenomics and Personalized Medicine Meet Our Editorial Board Member
Current Drug Targets Preface
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Prothymosin Alpha: An Alarmin and More...
Current Medicinal Chemistry The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering
Current Stem Cell Research & Therapy Combination of ZnO Nanoparticle with Marine Sponge Derived Dipeptide for Enhanced Anticancer Efficacy in Liver Cancer Cells and their Toxicity Evaluation on Embryonic Zebrafish
Current Analytical Chemistry Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Physiological Functions of Heat Shock Proteins
Current Protein & Peptide Science Chk1 Inhibitors for Novel Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Meet Our Associate Editorial Board Member
Current Pharmaceutical Biotechnology Applications of Nanoflowers in Biomedicine
Recent Patents on Nanotechnology A Scientific Approach to Anti-Ageing Therapies: State of the Art
Current Pharmaceutical Design Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective
Current Neurovascular Research In Silico Designing and Screening of Antagonists against Cancer Drug Target XIAP
Current Cancer Drug Targets Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Computational and Experimental Approaches for Modeling Gene Regulatory Networks
Current Pharmaceutical Design Advances and Application of DNA-functionalized Nanoparticles
Current Medicinal Chemistry